Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Weber

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Psycho-Oncology|January 15, 2009
Development of a screening tool for the identification of psychooncological treatment need in breast cancer patientsVerena Meraner, Johannes Giesinger, Georg Kemmler, et al.
Brachytherapy|October 4, 2016
Preclinical study investigating the potential of low-dose-rate brachytherapy with <sup>32</sup>P stents for the prevention of restenosis of paranasal neo-ostiaElmar Oestreicher, Harald Bartsch, Doris Mayr, et al.
American Journal of Medical Genetics. Part A|July 3, 2003
Life insurance and breast cancer risk assessment: adverse selection, genetic testing decisions, and discriminationKatrina Armstrong, Barbara Weber, Genevieve FitzGerald, et al.
Cancer Research|November 25, 2003
Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancerAngela DeMichele, Anne-Marie Martin, Rosemarie Mick, et al.
BMC Medical Informatics and Decision Making|November 13, 2012
The Computer-based Health Evaluation Software (CHES): a software for electronic patient-reported outcome monitoringBernhard Holzner, Johannes M Giesinger, Jakob Pinggera, et al.
European Journal of Human Genetics : EJHG|March 10, 2005
About the origin and development of hereditary conventional renal cell carcinoma in a four-generation t(3;8)(p14.1;q24.23) familyLaura Valle, Alberto Cascón, Lorenzo Melchor, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 2, 2009
Are gender-associated differences in quality of life in colorectal cancer patients disease-specific?Johannes Giesinger, Georg Kemmler, Verena Mueller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohortAngela DeMichele, Richard Aplenc, Jeffrey Botbyl, et al.
Familial Cancer|May 8, 2004
Cancer variation associated with the position of the mutation in the BRCA2 geneJan Lubinski, Catherine M Phelan, Parviz Ghadirian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriersKelly Metcalfe, Henry T Lynch, Parviz Ghadirian, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Psycho-Oncology|January 15, 2009
Development of a screening tool for the identification of psychooncological treatment need in breast cancer patientsVerena Meraner, Johannes Giesinger, Georg Kemmler, et al.
Brachytherapy|October 4, 2016
Preclinical study investigating the potential of low-dose-rate brachytherapy with <sup>32</sup>P stents for the prevention of restenosis of paranasal neo-ostiaElmar Oestreicher, Harald Bartsch, Doris Mayr, et al.
American Journal of Medical Genetics. Part A|July 3, 2003
Life insurance and breast cancer risk assessment: adverse selection, genetic testing decisions, and discriminationKatrina Armstrong, Barbara Weber, Genevieve FitzGerald, et al.
Cancer Research|November 25, 2003
Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancerAngela DeMichele, Anne-Marie Martin, Rosemarie Mick, et al.
BMC Medical Informatics and Decision Making|November 13, 2012
The Computer-based Health Evaluation Software (CHES): a software for electronic patient-reported outcome monitoringBernhard Holzner, Johannes M Giesinger, Jakob Pinggera, et al.
European Journal of Human Genetics : EJHG|March 10, 2005
About the origin and development of hereditary conventional renal cell carcinoma in a four-generation t(3;8)(p14.1;q24.23) familyLaura Valle, Alberto Cascón, Lorenzo Melchor, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 2, 2009
Are gender-associated differences in quality of life in colorectal cancer patients disease-specific?Johannes Giesinger, Georg Kemmler, Verena Mueller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohortAngela DeMichele, Richard Aplenc, Jeffrey Botbyl, et al.
Familial Cancer|May 8, 2004
Cancer variation associated with the position of the mutation in the BRCA2 geneJan Lubinski, Catherine M Phelan, Parviz Ghadirian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriersKelly Metcalfe, Henry T Lynch, Parviz Ghadirian, et al.
Pageof 7